51 |
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-00648 |
D.Del. |
|
|
|
|
52 |
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-00648 |
D.Del. |
|
|
|
|
53 |
Bayer Healthcare LLC et al v. Teva Pharamaceuticals USA, Inc. |
1:16-cv-01220 |
D.Del. |
|
|
|
|
54 |
Bayer Healthcare LLC et al v. Teva Pharamaceuticals USA, Inc. |
1:16-cv-01220 |
D.Del. |
|
|
|
|
55 |
Bayer Healthcare LLC et al v. Teva Pharamaceuticals USA, Inc. |
1:16-cv-01220 |
D.Del. |
|
|
|
|
56 |
Bayer Healthcare LLC et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-01221 |
D.Del. |
|
|
|
|
57 |
Bayer Healthcare LLC et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-01221 |
D.Del. |
|
|
|
|
58 |
Bayer Healthcare LLC et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-01221 |
D.Del. |
|
|
|
|
59 |
Amgen Inc. v. Teva Pharmaceuticals USA, Inc. et al |
1:17-cv-01809 |
D.Del. |
|
|
|
|
60 |
Adverio Pharma GmbH et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00112 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
61 |
Adverio Pharma GmbH et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00112 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
62 |
Adverio Pharma GmbH et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00112 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
63 |
Gilead Sciences, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00466 |
D.Del. |
|
|
|
|
64 |
Gilead Sciences, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00466 |
D.Del. |
|
|
|
|
65 |
iCeutica Pty Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00525 |
D.Del. |
|
|
|
|
66 |
iCeutica Pty Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00525 |
D.Del. |
|
|
|
|
67 |
Cosmo Technologies Limited v. Actavis Laboratories FL, Inc. et al |
1:18-cv-01006 |
D.Del. |
|
|
|
|
68 |
Valeant Pharmaceuticals International et al v. Actavis Laboratories FL, Inc. et al |
1:18-cv-01288 |
D.Del. |
|
|
|
|
69 |
Valeant Pharmaceuticals International et al v. Actavis Laboratories FL, Inc. et al |
1:18-cv-01288 |
D.Del. |
|
|
|
|
70 |
Valeant Pharmaceuticals International et al v. Actavis Laboratories FL, Inc. et al |
1:18-cv-01288 |
D.Del. |
|
|
|
|
71 |
Sun Pharma Global FZE et al v. Teva Pharmaceuticals USA, Inc. |
1:18-cv-01552 |
D.Del. |
|
|
|
|
72 |
Sun Pharma Global FZE et al v. Teva Pharmaceuticals USA, Inc. |
1:18-cv-01552 |
D.Del. |
|
|
|
|
73 |
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al |
1:22-cv-01462 |
D.Del. |
|
|
|
|
74 |
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al |
1:22-cv-01462 |
D.Del. |
|
|
|
|
75 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
76 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
77 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
78 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
79 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
80 |
PFIZER INC., et al v. TEVA PHARMACEUTICALS, et al |
2:00-cv-04168 |
D.N.J. |
|
|
|
|
81 |
PFIZER INC., et al v. TEVA PHARMACEUTICALS, et al |
2:00-cv-04168 |
D.N.J. |
|
|
|
|
82 |
PFIZER INC., et al v. TEVA PHARMACEUTICALS, et al |
2:00-cv-04168 |
D.N.J. |
|
|
|
|
83 |
PFIZER INC., et al v. TEVA PHARMACEUTICALS, et al |
2:00-cv-04168 |
D.N.J. |
|
|
|
|
84 |
CEPHALON, INC. v. MYLAN PHARMACEUTICAL, et al |
2:03-cv-01394 |
D.N.J. |
|
|
|
|
85 |
EISAI CO., LTD. et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:05-cv-05727 |
D.N.J. |
|
|
|
|
86 |
EISAI CO., LTD. et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:05-cv-05727 |
D.N.J. |
|
|
|
|
87 |
ASTRAZENECA PHARMACEUTICALS LP et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:06-cv-01528 |
D.N.J. |
|
|
|
|
88 |
ASTRAZENECA PHARMACEUTICALS LP et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:06-cv-01528 |
D.N.J. |
|
|
|
|
89 |
HOFFMANN-LA ROCHE INC. v. GATE PHARMACEUTICALS et al |
2:07-cv-04285 |
D.N.J. |
|
|
|
|
90 |
EISAI CO., LTD. et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:07-cv-05489 |
D.N.J. |
|
|
|
|
91 |
EISAI CO., LTD. et al v. TEVA PHARMACEUTICALS USA, INC. et al |
2:07-cv-05489 |
D.N.J. |
|
|
|
|
92 |
HOFFMANN-LA ROCHE INC. v. TEVA PHARMACEUTICALS USA, INC. et al |
2:09-cv-05283 |
D.N.J. |
|
|
|
|
93 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
94 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
95 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
96 |
VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. |
2:15-cv-06957 |
D.N.J. |
|
|
|
|
97 |
CELGENE CORPORATION v. PAR PHARMACEUTICAL, INC. et al |
2:17-cv-03159 |
D.N.J. |
|
|
|
|
98 |
Sebela International Limited et al v. ACTAVIS LABORATORIES FL, INC. et al |
2:17-cv-04789 |
D.N.J. |
|
|
|
|
99 |
Sebela International Limited et al v. ACTAVIS LABORATORIES FL, INC. et al |
2:17-cv-04789 |
D.N.J. |
|
|
|
|
100 |
Sebela International Limited et al v. ACTAVIS LABORATORIES FL, INC. et al |
2:17-cv-04789 |
D.N.J. |
|
|
|
|